Literature DB >> 12769613

Neuroplasticity within the mesoaccumbens dopamine system and its role in tobacco dependence.

David J K Balfour1.   

Abstract

The development of nicotine dependence is related to stimulation of the dopamine projections to the nucleus accumbens. This review considers the evidence that the addictive potential of nicotine depends upon its ability to elicit burst firing of these neurones and, thereby, evoke a large and sustained increase in the dopamine concentration in the extracellular space between the cells. This dopamine, it is argued, stimulates extra-synaptic dopamine receptors that mediate the responses underling the development of dependence. The review also considers the hypothesis that the two principal subdivisions of the structure, the core and shell, play different roles in the development of dependence. It proposes that the projections to the shell signal the presence of a rewarding stimulus and facilitate the acquisition of behaviours related to obtaining the reward. In contrast, the projections to the core, which are sensitised selectively by repeated exposure to the drug, mediate the transition to habit or Pavlovian responding to cues repetitively paired with the positive reinforcing properties of nicotine. Nicotine withdrawal, following a period of chronic exposure, diminishes the activity of the dopamine projections to the accumbal shell, a response that is thought to be the neural correlate of the anhedonia experienced by many abstinent smokers. The data suggest that plasticity within the principal mesoaccumbens dopamine projections play a central role in the development of nicotine dependence and that the mechanisms underlying the plasticity may provide putative targets for the treatment of tobacco dependence.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12769613     DOI: 10.2174/1568007023339076

Source DB:  PubMed          Journal:  Curr Drug Targets CNS Neurol Disord        ISSN: 1568-007X


  34 in total

1.  Preferential increase of extracellular dopamine in the rat nucleus accumbens shell as compared to that in the core during acquisition and maintenance of intravenous nicotine self-administration.

Authors:  Daniele Lecca; Fabio Cacciapaglia; Valentina Valentini; Janne Gronli; Saturnino Spiga; Gaetano Di Chiara
Journal:  Psychopharmacology (Berl)       Date:  2006-01-06       Impact factor: 4.530

2.  Conditioned reinforcement in rats established with self-administered nicotine and enhanced by noncontingent nicotine.

Authors:  Matthew I Palmatier; Xiu Liu; Gina L Matteson; Eric C Donny; Anthony R Caggiula; Alan F Sved
Journal:  Psychopharmacology (Berl)       Date:  2007-08-05       Impact factor: 4.530

3.  Impact of UK policy initiatives on use of medicines to aid smoking cessation.

Authors:  R West; M E DiMarino; J Gitchell; A McNeill
Journal:  Tob Control       Date:  2005-06       Impact factor: 7.552

4.  Ventral striatum/nucleus accumbens activation to smoking-related pictorial cues in smokers and nonsmokers: a functional magnetic resonance imaging study.

Authors:  Sean P David; Marcus R Munafò; Heidi Johansen-Berg; Stephen M Smith; Robert D Rogers; Paul M Matthews; Robert T Walton
Journal:  Biol Psychiatry       Date:  2005-07-14       Impact factor: 13.382

5.  A neurocomputational hypothesis for nicotine addiction.

Authors:  Boris S Gutkin; Stanislas Dehaene; Jean-Pierre Changeux
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-13       Impact factor: 11.205

Review 6.  Genetics and smoking cessation improving outcomes in smokers at risk.

Authors:  Caryn E Lerman; Robert A Schnoll; Marcus R Munafò
Journal:  Am J Prev Med       Date:  2007-12       Impact factor: 5.043

7.  Noradrenergic alpha1 receptors as a novel target for the treatment of nicotine addiction.

Authors:  Benoit Forget; Carrie Wertheim; Paola Mascia; Abhiram Pushparaj; Steven R Goldberg; Bernard Le Foll
Journal:  Neuropsychopharmacology       Date:  2010-03-31       Impact factor: 7.853

8.  Genetic variation in the serotonin pathway and smoking cessation with nicotine replacement therapy: new data from the Patch in Practice trial and pooled analyses.

Authors:  Sean P David; Elaine C Johnstone; Michael F G Murphy; Paul Aveyard; Boliang Guo; Caryn Lerman; Marcus R Munafò
Journal:  Drug Alcohol Depend       Date:  2008-06-17       Impact factor: 4.492

Review 9.  Pharmacogenetics of smoking cessation in general practice: results from the patch II and patch in practice trials.

Authors:  Sean P David; Elaine C Johnstone; Michael Churchman; Paul Aveyard; Michael F G Murphy; Marcus R Munafò
Journal:  Nicotine Tob Res       Date:  2011-01-25       Impact factor: 4.244

10.  Progressive and lasting amplification of accumbal nicotine-seeking neural signals.

Authors:  Karine Guillem; Laura L Peoples
Journal:  J Neurosci       Date:  2010-01-06       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.